News
Latest News and Press Releases
PassPort Technologies and Axcelead Drug Discovery Partners
Enter a comprehensive collaborative partnership in the field of drug discovery service using PassPort System, a new active...
Fujifilm and Axcelead Drug Discovery Partners begin collaborating to advance drug discovery solutions using iPSCs
To enhance the Process of Research and Development of Drug Candidates Tokyo/Kanagawa, July 10, 2019 ―FUJIFILM...
Transfer of All Axcelead Shares to Whiz Partners DDG Fund Completed
April 1, 2019 – Whiz Partners Inc. (hereinafter, “Whiz”), headquartered in Minato Ward, Tokyo, announced that it...
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Fujisawa, Japan and Dublin, Ireland, October 4, 2018 – Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as...
Announcement on starting preparation to become a company independent from Takeda
We are pleased to announce that Axcelead Drug Discovery Partners Inc. (“Axcelead”) preparation to become a company...